Abcam PLC (LSE:ABC) - Share price - Overview

Stock Report

Abcam PLC ABC

Last Price
GBX981.00

Day Change
11.00|1.13%

As of 26/05/2017
17:14:59 BST | GBX
Minimum 15 Minutes Delay.

Last Close970.00p
Day Range970.00 - 984.00
Mkt Cap1.98Bil
52-Wk Range619.00 - 987.00
Yield %0.84
ISINGB00B6774699
Volume296,080
P/E46.63
P/S11.49
P/CF41.71

Share Price

Total Returns 26/05/2017

 Chg (%)  
More ...
Abcam PLC14.94 
FTSE 100 TR GBP4.15
 
Financials
201420152016
More ...
Income Statement
Turnover127.95144.03171.67
Operating Profit43.3145.7346.32
Net Profit34.0537.3837.43
Reported EPS17.0218.5718.53
Balance Sheet
Current Assets90.3199.84118.86
Non Current Assets115.67149.42209.91
Total Assets206.59249.95329.56
Current Liabilities16.8321.0633.29
Total Liabilities25.6935.8468.37
Total Equity180.90214.10261.19
Cash Flow
Operating Cash Flow51.2548.8956.80
Net Change in Cash21.401.5510.40
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
201763.6024.9018.3638.952.129.871.02
201877.8029.8019.6732.551.6512.081.25

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
02/05/2017PurchaseGavin Wood889.755,70050,716.00
13/04/2017in Lieu of DividendMr. Alan Hirzel844.0017143.00
13/04/2017in Lieu of DividendGavin Wood844.00325.00
22/03/2017PurchaseMr. Alan Hirzel809.006,00048,540.00

Company Profile

Abcam PLC is a biotechnology company engaged in developing antibodies for life science research and clinical communities. It works on regulatory molecules and proteins in biological pathways to treat diseases like cancer and immune deficiency disorders.

Sector

Biotechnology

Market Position

198 of 1850 Companies

Index

FTSE AIM UK 50 ,FTSE AIM 100 ,FTSE AIM All Share

Outlook

(06/03/2017) "We believe that Abcam is well positioned to continue to deliver long-term value for all of our stakeholders"

Next Event 30/06/2017

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)33.0914.9716.81
Div Yld (E)1.223.624.07
PEG (E)1.690.410.76
ROCE49.76187.7717.40
Op Mrgn29.32-6.68-91.76
EPS Grwth19.5657.2727.18
Dividends
PreviousLatest
More ...
Record Date11/11/1617/03/17
Ex-Div10/11/1616/03/17
Paid02/12/1613/04/17
Amnt6.562.83

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr Murray Hennessy
Chief Executive OfficerMr. Alan Hirzel
Chief Financial OfficerGavin Wood
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.